Cyclin-Dependent Kinase 5 Mediates Neurotoxin-Induced Degradation of the Transcription Factor Myocyte Enhancer Factor 2
暂无分享,去创建一个
David S. Park | Z. Xia | Z. Mao | Xuemin Wang | M. Tong | Xiaoming Gong | Xiaoli Tang | Zixu Mao
[1] Jesús Avila,et al. Glycogen synthase kinase 3: a drug target for CNS therapies , 2004, Journal of neurochemistry.
[2] G. Johnson,et al. Cyclin‐dependent kinase‐5 in neurodegeneration , 2004, Journal of neurochemistry.
[3] David S. Park,et al. Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[4] Li-Huei Tsai,et al. Aberrant Cdk5 Activation by p25 Triggers Pathological Events Leading to Neurodegeneration and Neurofibrillary Tangles , 2003, Neuron.
[5] Li-Huei Tsai,et al. Cyclin-Dependent Kinase 5 and Neuronal Migration in the Neocortex , 2003, Neurosignals.
[6] E. Marra,et al. Cytochrome c, released from cerebellar granule cells undergoing apoptosis or excytotoxic death, can generate protonmotive force and drive ATP synthesis in isolated mitochondria , 2003, Journal of neurochemistry.
[7] Z. Xia,et al. ERK5 activation of MEF2-mediated gene expression plays a critical role in BDNF-promoted survival of developing but not mature cortical neurons , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[8] Junmin Peng,et al. Cdk5-Mediated Inhibition of the Protective Effects of Transcription Factor MEF2 in Neurotoxicity-Induced Apoptosis , 2003, Neuron.
[9] J. Julien,et al. Cycling at the interface between neurodevelopment and neurodegeneration , 2002, Cell Death and Differentiation.
[10] Yang Shi,et al. RNA Interference Reveals a Requirement for Myocyte Enhancer Factor 2A in Activity-dependent Neuronal Survival* , 2002, The Journal of Biological Chemistry.
[11] P. Davies,et al. Deregulation of cdk5, Hyperphosphorylation, and Cytoskeletal Pathology in the Niemann–Pick Type C Murine Model , 2002, The Journal of Neuroscience.
[12] L. Tsai,et al. A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains , 2002, FEBS letters.
[13] G. Johnson,et al. Cdk5 phosphorylates p53 and regulates its activity , 2002, Journal of neurochemistry.
[14] Jiankun Cui,et al. Dominant-interfering forms of MEF2 generated by caspase cleavage contribute to NMDA-induced neuronal apoptosis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[15] A. Kulkarni,et al. Cyclin‐dependent kinase 5 prevents neuronal apoptosis by negative regulation of c‐Jun N‐terminal kinase 3 , 2002, The EMBO journal.
[16] Li-Huei Tsai,et al. A decade of CDK5 , 2001, Nature Reviews Molecular Cell Biology.
[17] L. Tsai,et al. p35 and p39 Are Essential for Cyclin-Dependent Kinase 5 Function during Neurodevelopment , 2001, The Journal of Neuroscience.
[18] M. K. Meintzer,et al. Myocyte Enhancer Factor 2A and 2D Undergo Phosphorylation and Caspase-Mediated Degradation during Apoptosis of Rat Cerebellar Granule Neurons , 2001, The Journal of Neuroscience.
[19] S. R. Datta,et al. Transcription-dependent and -independent control of neuronal survival by the PI3K–Akt signaling pathway , 2001, Current Opinion in Neurobiology.
[20] J. Julien,et al. Deregulation of Cdk5 in a Mouse Model of ALS Toxicity Alleviated by Perikaryal Neurofilament Inclusions , 2001, Neuron.
[21] H. Pant,et al. Cyclin-dependent protein kinase 5 (Cdk5) and the regulation of neurofilament metabolism. , 2001, European journal of biochemistry.
[22] R. Maccioni,et al. The protein kinase Cdk5 , 2001 .
[23] R. Maccioni,et al. The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology. , 2001, European journal of biochemistry.
[24] Veeranna,et al. Neuronal Cyclin-Dependent Kinase 5 Activity Is Critical for Survival , 2001, The Journal of Neuroscience.
[25] Mark P. Mattson,et al. Apoptosis in neurodegenerative disorders , 2000, Nature Reviews Molecular Cell Biology.
[26] Junying Yuan,et al. Apoptosis in the nervous system , 2000, Nature.
[27] S. Lipton,et al. Antiapoptotic role of the p38 mitogen-activated protein kinase-myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[28] K. Ishiguro,et al. Calpain-dependent Proteolytic Cleavage of the p35 Cyclin-dependent Kinase 5 Activator to p25* , 2000, The Journal of Biological Chemistry.
[29] L. Tsai,et al. Neurotoxicity induces cleavage of p35 to p25 by calpain , 2000, Nature.
[30] L. Tsai,et al. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration , 1999, Nature.
[31] Z. Mao,et al. Calcineurin Enhances MEF2 DNA Binding Activity in Calcium-dependent Survival of Cerebellar Granule Neurons* , 1999, The Journal of Biological Chemistry.
[32] M E Greenberg,et al. Neuronal activity-dependent cell survival mediated by transcription factor MEF2. , 1999, Science.
[33] P. J. Steinbach,et al. Identification of Substrate Binding Site of Cyclin-dependent Kinase 5* , 1999, The Journal of Biological Chemistry.
[34] D. Kaplan,et al. Akt-Dependent Potentiation of L Channels by Insulin-Like Growth Factor-1 Is Required for Neuronal Survival , 1999, The Journal of Neuroscience.
[35] S. Al-Sarraj,et al. Cyclin-dependent kinase-5 is associated with lipofuscin in motor neurones in amyotrophic lateral sclerosis , 1998, Neuroscience Letters.
[36] R. Johnston,et al. Neuronal Cdc2-like Kinase (Nclk) Binds and Phosphorylates the Retinoblastoma Protein* , 1997, The Journal of Biological Chemistry.
[37] O. Ornatsky,et al. MEF2 Protein Expression, DNA Binding Specificity and Complex Composition, and Transcriptional Activity in Muscle and Non-muscle Cells* , 1996, The Journal of Biological Chemistry.
[38] J. Martín,et al. Mutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2C , 1996, Molecular and cellular biology.
[39] S. Imai,et al. Expression of a MADS box gene, MEF2D, in neurons of the mouse central nervous system: implication of its binary function in myogenic and neurogenic cell lineages , 1995, Neuroscience Letters.
[40] J. Brion,et al. Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5. , 1995, The American journal of pathology.
[41] G. Lyons,et al. Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[42] N. Copeland,et al. A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing , 1994, Molecular and cellular biology.
[43] B. Nadal-Ginard,et al. A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineage. , 1993, Development.
[44] S. Lipton,et al. hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors , 1993, Molecular and cellular biology.
[45] S. Lipton,et al. MEF2C, a MADS/MEF2-family transcription factor expressed in a laminar distribution in cerebral cortex. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[46] B. Nadal-Ginard,et al. Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors. , 1992, Genes & development.
[47] S. Paul,et al. N-methyl-D-aspartate exposure blocks glutamate toxicity in cultured cerebellar granule cells. , 1992, Molecular pharmacology.
[48] A. Schousboe,et al. Development of excitatory amino acid induced cytotoxicity in cultured neurons , 1990, International Journal of Developmental Neuroscience.
[49] S H Kaufmann,et al. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. , 1999, Annual review of biochemistry.
[50] K. Kinzler,et al. A simplified system for generating recombinant adenoviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[51] B. Black,et al. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. , 1998, Annual review of cell and developmental biology.
[52] Y. Barde,et al. Physiology of the neurotrophins. , 1996, Annual review of neuroscience.